The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials.
Open accessAbstract
Because individual studies evaluating the role of quinidine in the maintenance of sinus rhythm after cardioversion from chronic atrial fibrillation have involved relatively few patients, a meta-analysis of randomized control trials was performed. Six trials published between 1970 and 1984 were selected by two blinded reviewers based on study design and statistical analysis. Data from these six trials involving 808 patients were pooled after testing for homogeneity of treatment effects across trials. Life table estimates of the percent of patients still in sinus rhythm at 3, 6, and 12 months after cardioversion were constructed for quinidine and control groups. The proportion of patients remaining in sinus rhythm in the quinidine group was 69%, 58%, and 50% at 3, 6, and 12 months postcardioversion respectively. The proportion of patients remaining in sinus rhythm in the control group was 45%, 33%, and 25% at the same time intervals. The pooled rate difference, or difference in proportion of patients in sinus rhythm between quinidine and control groups, was 24%, 23%, and 24% at 3, 6, and 12 months of follow-up (p less than 0.001 at all time intervals). The unadjusted total mortality rate in the quinidine-treated patients was 2.9% and in the control group was 0.8%. The odds of dying in the quinidine-treated group were approximately three times that of the control group ("typical" odds ratio = 2.98, p less than 0.05). Thus, quinidine treatment is more effective than no antiarrhythmic therapy in suppressing recurrences of atrial fibrillation but appears to be associated with increased total mortality.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
The combination of estimates from different experiments
Cochran, W. G. (1954) · Biometrics · doi:10.2307/3001666 · Cited by 5,380
Beta blockade during and after myocardial infarction: An overview of the randomized trials
Yusuf, S., Peto, R., Lewis, J., Collins, R., & Sleight, P. (1985) · Progress in Cardiovascular Diseases · doi:10.1016/s0033-0620(85)80003-7 · Cited by 3,205
A method for assessing the quality of a randomized control trial
Chalmers, T. C., Smith, H., Blackburn, B., Silverman, B., Schroeder, B., Reitman, D., & Ambroz, A. (1981) · Controlled Clinical Trials · doi:10.1016/0197-2456(81)90056-8 · Cited by 1,349
Self-citationPublication bias—a problem in interpreting medical data
Begg, C. B., & Berlin, J. A. (1988) · Journal of the Royal Statistical Society. Series A (Statistics in Society) · doi:10.2307/2982993 · Cited by 814
Self-citationElectrical reversion of cardiac arrhythmias.
Lown, B. (1967) · Heart · doi:10.1136/hrt.29.4.469 · Cited by 660
Roden, D. M., Woosley, R. L., & Primm, R. K. (1986) · American Heart Journal · doi:10.1016/0002-8703(86)90010-4 · Cited by 488
Meta-analytic Evidence Against Prophylactic Use of Lidocaine in Acute Myocardial Infarction
Hine, L. K. (1989) · Archives of Internal Medicine · doi:10.1001/archinte.149.12.2694 · Cited by 249
The Cardiac Arrhythmia Suppression Trial (CAST)
Ruskin, J. N. (1989) · New England Journal of Medicine · doi:10.1056/nejm198908103210608 · Cited by 233
Cited by
Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J. J., Blomström-Lundqvist, C., Boriani, G., Castella, M., Dan, G.-A., Dilaveris, P. E., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehaa612 · Cited by 9,971
Impact of Atrial Fibrillation on the Risk of Death: The Framingham Heart Study
Benjamin, E. J., Wolf, P. A., D’Agostino, R. B., Silbershatz, H., Kannel, W. B., & Levy, D. (1998) · Circulation · doi:10.1161/01.cir.98.10.946 · Cited by 4,575
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
Hunt, S. A. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.08.022 · Cited by 4,154
2005 WRITING COMMITTEE MEMBERS, Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.192065 · Cited by 3,720
Fuster, V., Rydén, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Le Heuzey, J.-Y., Kay, G. N., Lowe, J. E., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.177292 · Cited by 2,805
Self-citationVan Gelder, I. C., Hagens, V. E., Bosker, H. A., Kingma, J. H., Kamp, O., Kingma, T., Said, S. A., Darmanata, J. I., Timmermans, A. J. M., Tijssen, J. G. P., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021375 · Cited by 2,359
WRITING COMMITTEE MEMBERS, Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.167586 · Cited by 2,251
Self-citationSurrogate End Points in Clinical Trials: Are We Being Misled?
Fleming, T. R., & DeMets, D. L. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-7-199610010-00011 · Cited by 1,651
Rhythm control versus rate control for atrial fibrillation and heart failure
Roy, D., Talajic, M., Nattel, S., Wyse, D. G., Dorian, P., Lee, K. L., Bourassa, M. G., Arnold, J. M. O., Buxton, A. E., Camm, A. J., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708789 · Cited by 1,585
2009 WRITING GROUP TO REVIEW NEW EVIDENCE AND UPDATE THE 2005 GUIDELINE FOR THE MANAGEMENT OF PATIENTS WITH CHRONIC HEART FAILURE WRITING ON BEHALF OF THE 2005 HEART FAILURE WRITING COMMITTEE, Jessup, M., Abraham, W. T., Casey, D. E., Feldman, A. M., Francis, G. S., Ganiats, T. G., Konstam, M. A., Mancini, D. M., Rahko, P. S., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.192064 · Cited by 1,419
Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., Michl, K., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.11.013 · Cited by 1,374
ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary
Fuster, V., Rydén, L. E., Asinger, R. W., Cannom, D. S., Crijns, H. J., Frye, R. L., Halperin, J. L., Kay, G. N., Klein, W. W., Lévy, S., et al. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01587-x · Cited by 1,348
Self-citationAmiodarone to Prevent Recurrence of Atrial Fibrillation
Roy, D., Talajic, M., Dorian, P., Connolly, S., Eisenberg, M. J., Green, M., Kus, T., Lambert, J., Dubuc, M., Gagné, P., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003303421302 · Cited by 1,143
Hohnloser, S. H., Kuck, K.-H., & Lilienthal, J. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03230-x · Cited by 1,134
Dofetilide in Patients with Congestive Heart Failure and Left Ventricular Dysfunction
Torp-Pedersen, C., Møller, M., Bloch-Thomsen, P. E., Køber, L., Sandøe, E., Egstrup, K., Agner, E., Carlsen, J., Videbæk, J., Marchant, B., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909163411201 · Cited by 1,012
Fuster, V., Rydén, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Kay, G. N., Le Huezey, J.-Y., Lowe, J. E., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.09.013 · Cited by 924
Fuster, V., Rydén, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Kay, G. N., Le Huezey, J.-Y., Lowe, J. E., et al. (2011) · Circulation · doi:10.1161/cir.0b013e318214876d · Cited by 859
Amiodarone as Compared with Lidocaine for Shock-Resistant Ventricular Fibrillation
Dorian, P., Cass, D., Schwartz, B., Cooper, R., Gelaznikas, R., & Barr, A. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013029 · Cited by 810
What Clinicians Should Know About the QT Interval
Al-Khatib, S. M., LaPointe, N. M. A., Kramer, J. M., & Califf, R. M. (2003) · JAMA · doi:10.1001/jama.289.16.2120 · Cited by 667
Writing Committee Members, Fuster, V., Ryden, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Le Heuzey, J.-Y., Kay, G. N., et al. (2006) · Europace · doi:10.1093/europace/eul097 · Cited by 667
Self-citationPrystowsky, E. N., Benson, D. W., Fuster, V., Hart, R. G., Kay, G. N., Myerburg, R. J., Naccarelli, G. V., & Wyse, D. G. (1996) · Circulation · doi:10.1161/01.cir.93.6.1262 · Cited by 635
Dorian, P., Jung, W., Newman, D., Paquette, M., Wood, K., Ayers, G. M., Camm, J., Akhtar, M., & Luderitz, B. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00886-x · Cited by 627
Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation
Flaker, G. C., Blackshear, J. L., McBride, R., Kronmal, R. A., Halperin, J. L., & Hart, R. G. (1992) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(92)90003-6 · Cited by 632
Dronedarone for Maintenance of Sinus Rhythm in Atrial Fibrillation or Flutter
Singh, B. N., Connolly, S. J., Crijns, H. J. G. M., Roy, D., Kowey, P. R., Capucci, A., Radzik, D., Aliot, E. M., & Hohnloser, S. H. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa054686 · Cited by 631
Moher, D., Pham, B., Lawson, M., & Klassen, T. (2003) · Health Technology Assessment · doi:10.3310/hta7410 · Cited by 500
Deedwania, P. C., Singh, B. N., Ellenbogen, K., Fisher, S., Fletcher, R., & Singh, S. N. (1998) · Circulation · doi:10.1161/01.cir.98.23.2574 · Cited by 506
(2001) · European Heart Journal · doi:10.1053/euhj.2001.2983 · Cited by 494
Rate Control vs Rhythm Control in Patients With Nonvalvular Persistent Atrial Fibrillation
Opolski, G., Torbicki, A., Kosior, D. A., Szulc, M., Wozakowska-Kapłon, B., Kołodziej, P., & Achremczyk, P. (2004) · Chest · doi:10.1378/chest.126.2.476 · Cited by 473
Van Gelder, I. C., Crijns, H. J., Van Gilst, W. H., Verwer, R., & Lie, K. I. (1991) · The American Journal of Cardiology · doi:10.1016/0002-9149(91)90707-r · Cited by 470
Lesko, L., & Atkinson, A. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.347 · Cited by 465
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
Fuster, V., Rydén, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Le Heuzey, J.-Y., Kay, G. N., Lowe, J. E., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.018 · Cited by 467
What contributions do languages other than English make on the results of meta-analyses?
Moher, D., Pham, Klassen, T. P., Schulz, K. F., Berlin, J. A., Jadad, A. R., & Liberati, A. (2000) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(00)00188-8 · Cited by 453
Self-citationSingh, S., Zoble, R. G., Yellen, L., Brodsky, M. A., Feld, G. K., Berk, M., & Billing, C. B. (2000) · Circulation · doi:10.1161/01.cir.102.19.2385 · Cited by 433
Powe, N. R. (1994) · Archives of Ophthalmology · doi:10.1001/archopht.1994.01090140115033 · Cited by 433
Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation
Lafuente-Lafuente, C., Valembois, L., Bergmann, J.-F., & Belmin, J. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005049.pub4 · Cited by 423
Calkins, H., Langberg, J., Sousa, J., el-Atassi, R., Leon, A., Kou, W., Kalbfleisch, S., & Morady, F. (1992) · Circulation · doi:10.1161/01.cir.85.4.1337 · Cited by 399
Moher, Cook, Jadad, Tugwell, Moher, Jones, Pham, & Klassen (1999) · Health Technology Assessment · doi:10.3310/hta3120 · Cited by 368
Cellular electropharmacology of amiodarone
Kodama, I. (1997) · Cardiovascular Research · doi:10.1016/s0008-6363(97)00114-4 · Cited by 341
Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial
FETSCH, T. (2004) · European Heart Journal · doi:10.1016/j.ehj.2004.04.015 · Cited by 334
Brieger, D., Amerena, J., Attia, J., Bajorek, B., Chan, K. H., Connell, C., Freedman, B., Ferguson, C., Hall, T., Haqqani, H., et al. (2018) · Heart, Lung and Circulation · doi:10.1016/j.hlc.2018.06.1043 · Cited by 327
Management of Atrial Fibrillation
Wood, A. J. J., & Pritchett, E. L. C. (1992) · New England Journal of Medicine · doi:10.1056/nejm199205073261906 · Cited by 325
Atrial fibrillation: current knowledge and recommendations for management*1
LEVY, S. (1998) · European Heart Journal · doi:10.1053/euhj.1998.1050 · Cited by 323
Dronedarone for prevention of atrial fibrillation: A dose-ranging study
Touboul, P. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)00321-x · Cited by 315
Drug-induced QT interval prolongation: mechanisms and clinical management
Nachimuthu, S., Assar, M. D., & Schussler, J. M. (2012) · Therapeutic Advances in Drug Safety · doi:10.1177/2042098612454283 · Cited by 307
Evidence-Based Analysis of Amiodarone Efficacy and Safety
Connolly, S. J. (1999) · Circulation · doi:10.1161/01.cir.100.19.2025 · Cited by 307
Lafuente-Lafuente, C., Mouly, S., Longás-Tejero, M. A., Mahé, I., & Bergmann, J.-F. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.7.719 · Cited by 288
Maintenance of sinus rhythm in patients with atrial fibrillation
(2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00559-x · Cited by 281
Gosselink, A. T. M. (1992) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1992.03480240051033 · Cited by 281
Crijns, H. J., Van Gelder, I. C., Van Gilst, W. H., Hillege, H., Gosselink, A. M., & Lie, K. I. (1991) · The American Journal of Cardiology · doi:10.1016/0002-9149(91)90828-9 · Cited by 275
Implantable Cardioverter-Defibrillators: Expanding Indications and Technologies
Goldberger, Z., & Lampert, R. (2006) · JAMA · doi:10.1001/jama.295.7.809 · Cited by 271
Kühlkamp, V., Schirdewan, A., Stangl, K., Homberg, M., Ploch, M., & Beck, O. A. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00693-8 · Cited by 256
Propafenone versus sotalol for suppression of recurrent symptomatic atrial fibrillation
Reimold, S. C., Cantillon, C. O., Friedman, P. L., & Antman, E. M. (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)90511-a · Cited by 253
Self-citationFalk, R. H., Pollak, A., Singh, S. N., & Friedrich, T. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(96)00506-2 · Cited by 215
Wireless smartphone ECG enables large-scale screening in diverse populations
HABERMAN, Z. C., JAHN, R. T., BOSE, R., TUN, H., SHINBANE, J. S., DOSHI, R. N., CHANG, P. M., & SAXON, L. A. (2015) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.12634 · Cited by 212
Proarrhythmia, cardiac arrest and death in young patients receiving encainide and flecainide
Fish, F. A., Gillette, P. C., & Benson, D. W. (1991) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(91)90586-x · Cited by 193
Hakalahti, A., Biancari, F., Nielsen, J. C., & Raatikainen, M. J. P. (2015) · Europace · doi:10.1093/europace/euu376 · Cited by 191
Kirchhof, P., Andresen, D., Bosch, R., Borggrefe, M., Meinertz, T., Parade, U., Ravens, U., Samol, A., Steinbeck, G., Treszl, A., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60570-4 · Cited by 176
Ellenbogen, K. A., Dias, V. C., Plumb, V. J., Heywood, J. T., & Mirvis, D. M. (1991) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(91)90743-s · Cited by 160
Suppression of paroxysmal atrial tachyarrhythmias—results of the SOPAT trial
PATTEN, M., MAAS, R., BAUER, P., LUDERITZ, B., SONNTAG, F., DLUZNIEWSKI, M., HATALA, R., OPOLSKI, G., MULLER, H., & MEINERTZ, T. (2004) · European Heart Journal · doi:10.1016/j.ehj.2004.06.014 · Cited by 157
Resolution of cardiomyopathy after ablation of atrial flutter
Luchsinger, J. A., & Steinberg, J. S. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00183-1 · Cited by 121
Short- and long-term efficacy and safety of flecainide acetate for supraventricular arrhythmias
Hohnloser, S. H., & Zabel, M. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)91071-b · Cited by 74
Pharmacologic Treatment of Depression in Patients With Heart Disease
Roose, S. P., & Miyazaki, M. (2005) · Psychosomatic Medicine · doi:10.1097/01.psy.0000163455.43226.bf · Cited by 76
Rhodes, L. A., Walsh, E. P., & Saul, J. P. (1995) · American Heart Journal · doi:10.1016/0002-8703(95)90448-4 · Cited by 66
Management of Atrial Fibrillation in Adults: Prevention of Thromboembolism and Symptomatic Treatment
Blackshear, J. L., Kopecky, S. L., Litin, S. C., Safford, R. E., & Hammill, S. C. (1996) · Mayo Clinic Proceedings · doi:10.4065/71.2.150 · Cited by 67
Nergardh, A. K., Rosenqvist, M., Nordlander, R., & Frick, M. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehl544 · Cited by 65
Alterations in atrial electrophysiology associated with chronic atrial fibrillation in man
Kamalvand, K. (1999) · European Heart Journal · doi:10.1053/euhj.1998.1404 · Cited by 47
Chapter 12: Systematic Review of Prognostic Tests
Rector, T. S., Taylor, B. C., & Wilt, T. J. (2012) · Journal of General Internal Medicine · doi:10.1007/s11606-011-1899-y · Cited by 37
Metadata
- Authors
- Coplen, S. E., Antman, E. M., Berlin, J. A., Hewitt, P., & Chalmers, T. C.
- Venue
- Circulation
- Published
- 1990-10
- Volume
- 82
- Issue
- 4
- Pages
- 1106-1116
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W1841210729
- Cited by
- 945
- References
- 27
- FWCI
- 8.92
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.